Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in bulgaria.
about
The New and Old Europe: East-West Split in Pharmaceutical Spending.Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs.How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.Transposition and implementation of EU rare disease policy in Eastern Europe.Pharmaceutical expenditure dynamics in the Balkan countries.An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries.
P2860
Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in bulgaria.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Prospects of risk-sharing agre ...... deficit spending in bulgaria.
@ast
Prospects of risk-sharing agre ...... deficit spending in bulgaria.
@en
type
label
Prospects of risk-sharing agre ...... deficit spending in bulgaria.
@ast
Prospects of risk-sharing agre ...... deficit spending in bulgaria.
@en
prefLabel
Prospects of risk-sharing agre ...... deficit spending in bulgaria.
@ast
Prospects of risk-sharing agre ...... deficit spending in bulgaria.
@en
P2860
P356
P1476
Prospects of risk-sharing agre ...... f deficit spending in bulgaria
@en
P2093
Rumen Stefanov
P2860
P356
10.3389/FPUBH.2015.00064
P577
2015-04-22T00:00:00Z